Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are increasing in incidence. Clinicians urgently need a method that can effectively predict the prognosis of GEP-NENs.A total of 14770 GEP-NENs patients with pathologically confirmed between 1975 and 2016 were obtained from the surveillance, epidemiology, and end results database. All the patients were divided into primary (n = 10377) and validation (n = 4393) cohorts based on the principle of random grouping. Multivariate Cox proportional hazards proportional hazards regression analysis was performed to evaluate predictors associated with overall survival, and a nomogram was constructed based on the primary cohort. An independent external validation cohort and comparison with the eighth edition American Joint Committee on Cancer TNM staging system were subsequently used to assess the predictive performance of the nomogram.The multivariate Cox model indicated that age, tumour differentiation, and distant metastases were independent predictors associated with overall survival. With respect to the primary cohort, the nomogram exhibited better discriminatory power than the TNM classification (C-index: 0.821 vs 0.738). Discrimination was also superior to that of TNM classification for the validation cohort (C-index: 0.823 vs 0.738). The calibrated nomogram predicted 3- and 5-years survival rate that closely corresponded to the actual survival rate.This study developed and validated a prognostic nomogram applied to patients with GEP-NENs, which may help clinicians make reasonable prognostic judgments and treatment plans to a certain extent.

Xie S ，Li L ，Wang X ，Li L ... -  《-》

Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.

Fang C ，Wang W ，Feng X ，Sun J ，Zhang Y ，Zeng Y ，Wang J ，Chen H ，Cai M ，Lin J ，Chen M ，Chen Y ，Li Y ，Li S ，Chen J ，Zhou Z ... -  《-》

A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.

Wu Z ，Shang G ，Zhang K ，Wang W ，Fan M ，Lin R ... -  《-》

Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.

Xu Z ，Wang L ，Dai S ，Chen M ，Li F ，Sun J ，Luo F ... -  《JAMA Network Open》

Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.

Shi H ，Zhang Q ，Han C ，Zhen D ，Lin R ... -  《BMC Endocrine Disorders》